Journal of Vaccine Research 2024, Vol.14, No.6, 278-286 http://medscipublisher.com/index.php/jvr 285 Chaves S., Fischer G., Groeger J., Patel P., Thompson N., Teshale E., Stevenson K., Yano V., Armstrong G., Samandari T., Kamili S., Drobeniuc J., and Hu D., 2012, Persistence of long-term immunity to hepatitis B among adolescents immunized at birth, Vaccine, 30(9): 1644-1649. https://doi.org/10.1016/j.vaccine.2011.12.106 Chen C., Yang J., Lin S., Sun C., Bai C., You S., Chen C., Kao J., Chen P., and Chen D., 2015, Slow decline of hepatitis B burden in general population: results from a population-based survey and longitudinal follow-up study in Taiwan, Journal of Hepatology, 63(2): 354-363. https://doi.org/10.1016/j.jhep.2015.03.013 Chlibek R., Von Sonnenburg F., Van Damme P., Smetana J., Tichy P., Gunapalaiah B., Leyssen M., and Jacquet J., 2011, Antibody persistence and immune memory 4 years post-vaccination with combined hepatitis A and B vaccine in adults aged over 40 years, Journal of Travel Medicine, 18(2): 145-148. https://doi.org/10.1111/j.1708-8305.2010.00499.x Ciotti J., Valtcheva M., and Cross A., 2020, Effects of MS disease-modifying therapies on responses to vaccinations: a review, Multiple Sclerosis and Related Disorders, 45: 102439. https://doi.org/10.1016/j.msard.2020.102439 Di Lello F.A., Martínez A.P., and Flichman D.M., 2022, Insights into induction of the immune response by the hepatitis B vaccine, World Journal of Gastroenterology, 28(31): 4249-4259. https://doi.org/10.3748/wjg.v28.i31.4249 Flores J., Thompson A., Ryan M., and Howell J., 2022, The global impact of hepatitis B vaccination on hepatocellular carcinoma, Vaccines, 10(5): 793. https://doi.org/10.3390/vaccines10050793 Gilca V., De Serres G., Boulianne N., Murphy D., Ouakki M., De Wals P., Trudeau G., Massé R., and Dionne M., 2013, Long-term persistence of immunity after vaccination of pre-adolescents with low doses of a recombinant hepatitis B vaccine, Human Vaccines & Immunotherapeutics, 9: 1685-1690. https://doi.org/10.4161/hv.25015 Gomes C., Wong R., and Gish R., 2019, Global perspective on hepatitis B virus infections in the era of effective vaccines, Clinics in Liver Disease, 23(3): 383-399. https://doi.org/10.1016/j.cld.2019.04.001 Huang H., Xu C., Liu L., Chen L., Zhu X., Chen J., Feng J., Chen T., Xu B., Yang J., Xu B., Pan M., Dai Y., Hu Y., and Zhou Y., 2020, Increased protection of earlier use of immunoprophylaxis in preventing perinatal transmission of hepatitis B virus, Clinical Infectious Diseases, Online ahead of print. https://doi.org/10.1093/cid/ciaa898 Kao J., 2015, Hepatitis B vaccination and prevention of hepatocellular carcinoma, Best Practice & Research: Clinical Gastroenterology, 29(6): 907-917. https://doi.org/10.1016/j.bpg.2015.09.011 Klinger G., Chodick G., and Levy I., 2018, Long-term immunity to hepatitis B following vaccination in infancy: real-world data analysis, Vaccine, 36(17): 2288-2292. https://doi.org/10.1016/j.vaccine.2018.03.028 Launay O., Rosenberg A., Rey D., Pouget N., Michel M., Reynes J., Neau D., Raffi F., Piroth L., and Carrat F., 2016, Long-term immune response to hepatitis B virus vaccination regimens in adults with human immunodeficiency virus 1: secondary analysis of a randomized clinical trial, JAMA Internal Medicine, 176(5): 603-610. https://doi.org/10.1001/jamainternmed.2016.0741 Lee H., Lee J., and Ahn S., 2020, Hepatitis B virus cure: targets and future therapies, International Journal of Molecular Sciences, 22(1): 213. https://doi.org/10.3390/ijms22010213 PMid: 33406697 Liu J., Liang W., Jing W., and Liu M., 2019, Countdown to 2030: eliminating hepatitis B disease, China, Bulletin of the World Health Organization, 97: 230-238. https://doi.org/10.2471/BLT.18.219469 PMid: 30992681 Liu Y., Ren J., Wu Z., Shen L., Shan H., Dai X., Li J., Qiu Y., Ren W., Yao J., and Li L., 2020, The effect of hepatitis B vaccination after five years on an entire population in an insular region of Southeast China, Human Vaccines & Immunotherapeutics, 17: 1530-1535. https://doi.org/10.1080/21645515.2020.1814096 Lu C., Ni Y., Chiang B., Chen P., Chang M., Chang L., Su I., Kuo H., Huang L., Chen D., and Lee C., 2008, Humoral and cellular immune responses to a hepatitis B vaccine booster 15-18 years after neonatal immunization, The Journal of Infectious Diseases, 197(10): 1419-1426. https://doi.org/10.1086/587695 Ma Z., Zhang E., Gao S., Xiong Y., and Lu M., 2019, Toward a functional cure for hepatitis B: the rationale and challenges for therapeutic targeting of the B cell immune response, Frontiers in Immunology, 10: 2308. https://doi.org/10.3389/fimmu.2019.02308 Marshall H., Nolan T., Domingo D., Rombo L., Sokal E., Mares J., Casanovas J., Kuriyakose S., Leyssen M., and Jacquet J., 2010, Long-term (5-year) antibody persistence following two- and three-dose regimens of a combined hepatitis A and B vaccine in children aged 1-11 years, Vaccine, 28(27): 4411-4415. https://doi.org/10.1016/j.vaccine.2010.04.040 Shen S., Ge S., Zhang Z., Jiao Y., Li Q., Liang Y., and Li S., 2022, Persistence of immunity in adults after 1, 5 and 10 years with recombinant hepatitis B vaccine in Beijing in 2010-2020, Vaccines, 10(2): 181. https://doi.org/10.3390/vaccines10020181 PMid: 35204073
RkJQdWJsaXNoZXIy MjQ4ODYzNQ==